Devyser Diagnostics Future Growth
Future criteria checks 5/6
Devyser Diagnostics is forecast to grow earnings and revenue by 119.5% and 31.4% per annum respectively. EPS is expected to grow by 119.9% per annum. Return on equity is forecast to be 11.2% in 3 years.
Key information
119.5%
Earnings growth rate
119.9%
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | 31.4% |
| Future return on equity | 11.2% |
| Analyst coverage | Low |
| Last updated | 22 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 423 | 51 | 23 | 60 | 4 |
| 12/31/2025 | 319 | 0 | -41 | -5 | 4 |
| 12/31/2024 | 219 | -67 | -127 | -58 | 4 |
| 9/30/2024 | 198 | -71 | -124 | -59 | N/A |
| 6/30/2024 | 196 | -54 | -111 | -60 | N/A |
| 3/31/2024 | 181 | -46 | -120 | -67 | N/A |
| 12/31/2023 | 169 | -54 | -102 | -70 | N/A |
| 9/30/2023 | 158 | -57 | -100 | -69 | N/A |
| 6/30/2023 | 143 | -60 | -102 | -67 | N/A |
| 3/31/2023 | 136 | -60 | -79 | -52 | N/A |
| 12/31/2022 | 127 | -46 | -66 | -40 | N/A |
| 9/30/2022 | 117 | -40 | -53 | -33 | N/A |
| 6/30/2022 | 110 | -35 | -40 | -24 | N/A |
| 3/31/2022 | 101 | -27 | -43 | -29 | N/A |
| 12/31/2021 | 93 | -21 | -25 | -16 | N/A |
| 12/31/2020 | 66 | -11 | -3 | 1 | N/A |
| 12/31/2019 | 64 | 7 | 5 | 15 | N/A |
| 12/31/2018 | 48 | 1 | 1 | 6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OL0 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: OL0 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: OL0 is expected to become profitable in the next 3 years.
Revenue vs Market: OL0's revenue (31.4% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: OL0's revenue (31.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: OL0's Return on Equity is forecast to be low in 3 years time (11.2%).